In the vignette titled "Dramatic Cutaneous Psoriasis Improvement in a Patient With the Human Immunodeficiency Virus Treated With 2′,3′-Dideoxycytidine and Ritonavir," published in the April 1997 issue of the ARCHIVES (1997;133:531), the chemical name of a drug was printed incorrectly. The correct name should be 2′,3′-dideoxy,3′-thyacytidine instead of 2′,3′-dideoxycytidine.
Error in Chemical Name. Arch Dermatol. 1998;134(4):452. doi:10.1001/archderm.134.4.452